期刊文献+

叶黄素微囊分散片的成型处方优选 被引量:1

Optimization of Shaping Prescription of Lutein Microencapsulation Dispersible Tablet
原文传递
导出
摘要 目的:优选叶黄素微囊分散片的成型处方。方法:以外观、混悬性、崩解时间及溶出度为综合评价指标,采用单因素试验确定填充剂及润滑剂种类和用量、崩解剂、润湿剂及溶胀性辅料的种类,通过正交试验优选叶黄素微囊分散片的成型工艺处方。结果:最佳处方为以25%羧甲基淀粉钠(CMS-Na)-交联聚乙烯吡咯烷酮(PVPP)(1∶1.5)为崩解剂,6%羟丙基纤维素(HPC)为溶胀性辅料,70%乙醇溶液为润湿剂,所制备的分散片在80 s内完全崩解,10 min溶出度>90%。结论:优选的处方辅料种类及比例适宜、片面光洁,崩解迅速、溶出度高,具有良好的开发前景。 Objective: To optimize forming prescription of lutein microcapsule dispersible tablet. Method: With appearance, suspension, disintegration time and dissolution as comprehensive evaluation indexes, type and amount of filler and lubricant, type of disintegrating agent, wetting agent and swelling accessories were determined by single factor test, forming technology prescription of lutein mierocapsule dispersible tablet was optimized by orthogonal test. Result: Optimum forming prescription was: with consisted of 25% CMS-Na and PVPP (1: 1) as disintegrating agent, 6% HPC as swelling accessory, and 70% ethanol as wetting agent. These prepared dispersible tablet could disintegrate completely within 80 s, dissolution was more than 90% within ten min. Conclusion : This optimized formulation was rational and stable with smooth appearance, rapid disintegration, high dissolution and good development prospect.
出处 《中国实验方剂学杂志》 CAS 北大核心 2012年第22期45-48,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 石河子大学生研究训练计划项目(SRP2012216) 科技人员服务企业行动项目(SQ2009GJG4102765)
关键词 叶黄素微囊 分散片 成型工艺 正交试验 lutein microcapsule dispersible tablet forming process orthogonal test
  • 相关文献

参考文献10

二级参考文献27

  • 1张宇,金玲宇,朱仝飞,焦成美,李三鸣.五味消毒饮分散片的处方优化及工艺考察[J].中国药剂学杂志(网络版),2008(3):109-115. 被引量:1
  • 2刘郁,全红梅,刘连新.中药分散片及工艺研究进展[J].时珍国医国药,2005,16(6):538-540. 被引量:33
  • 3罗云,周俊,宋金春.利用均匀设计筛选银黄分散片的处方[J].中国医院药学杂志,2005,25(8):721-723. 被引量:6
  • 4王小平,毛晓敏,蔡治纲.三黄分散片中黄芩苷的体外溶出度研究[J].中成药,2006,28(7):1054-1055. 被引量:7
  • 5中国药典[S].2010年版.二部.附录ⅨJ.
  • 6中国药典一部[S].2010年:32.
  • 7Frederick Khnahik,Paul S Bernstein, Donita L Garland. Identification of lutein and zeaxenthin oxidantion products in human and monkey retinas [ J ]. Invest Ophthalmol Vis Sci, 1997,38 : 1802.
  • 8Handelman G J, Dratz E A, Reay C C,et al. Carotenoids in the human macula and whole retina [ J ]. Invest Ophthalmol Vis Sci, 1988, 29: 850.
  • 9Baun O, Vinding T, Krogh E. Natural course in fellow eyes of patients with unilateral age related exudative maculopathy. A fluorescein angiograpbic 4 year follow up of 45 patients [ J]. Acta Ophthalmol (Copenh) , 1995, 71(3) : 398.
  • 10Krinsky N I, Landrum J T, Bone R A. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye [J]. Annu Rev Nutr, 2003, 23: 171.

共引文献207

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部